The Pathology Core is designed to provide the investigators of the Program Project with expert? pathologic evaluation of all soft tissue sarcomas (STS) that present to Memorial Sloan-Kettering Cancer? Center. The Core will provide a centralized, comprehensive facility for tissue-based research. The resource will? provide tissues and associated data in an equitable and ethical manner, provide professional expertise in? histo- and molecular pathology and assist and perform tissue-based experimentation. The human tissues? used for research studies are obtained under existing IRB-approved protocols.
The specific aims are:? 1. To provide consistent, expert pathologic characterization of all STS specimens resected at MSKCC,? including a description of gross appearance, histologic type, tumor grade, necrosis, and surgical margins.? 2. To supervise the procurement of normal and neoplastic human tissue samples and maintain a bank of? frozen sarcoma tissue for special studies conducted under the different projects. This process ensures that? adequate amounts of correctly identified and processed tissue reach the appropriate laboratories.? 3. To provide expert histologic review for individual projects, including tumor viability and assessment of? tumor response to various investigational agents used in different studies, either in post-treated surgical? specimens or xenografts. Histologic response assessment to various inhibitors will also be provided for the? preclinical in vivo mouse models, as well as histologic expertise for the murine knockout/transgenic models .? 4. To assist in performing high-throughput tissue microarray (TMA) and interpreting immunohistochemical? (IHC) and in situ hybridization studies (ISH) for validation studies of various microarray projects. An ATA-27? Beecher Automated tissue arrayer will be used to construct TMAs of varying sarcoma types and? accompanying normal tissues. Quantitative image analysis of the IHC/ISH results will be performed using an? ACIS II (automated cellular imaging system) Chromavision slide scanner tissue arrayer. Assistance with the? development of the Clinical Tissue Microarray (ClinTMA) Database by the Bioinformatics Core will be? provided, and results will be entered into this database as continuous values.? These aims offer a substantial infrastructure to the STS Program Project and allows Core B to provide the? required services in a cost effective manner.?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA047179-16
Application #
7448524
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
16
Fiscal Year
2007
Total Cost
$220,651
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Xie, Yuanyuan; Cao, Zhen; Wong, Elissa Wp et al. (2018) COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors. J Clin Invest 128:1442-1457
Weinreb, Ilan; Bishop, Justin A; Chiosea, Simion I et al. (2018) Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland. Am J Surg Pathol 42:442-452
Kao, Yu-Chien; Sung, Yun-Shao; Zhang, Lei et al. (2017) Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1. Genes Chromosomes Cancer 56:42-50
Seifert, Adrian M; Zeng, Shan; Zhang, Jennifer Q et al. (2017) PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res 23:454-465
Argani, Pedram; Zhang, Lei; Reuter, Victor E et al. (2017) RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH. Am J Surg Pathol 41:655-662
Argani, Pedram; Zhong, Minghao; Reuter, Victor E et al. (2016) TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Am J Surg Pathol 40:723-37
Tan, Marcus C B; Brennan, Murray F; Kuk, Deborah et al. (2016) Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Ann Surg 263:593-600
Specht, Katja; Zhang, Lei; Sung, Yun-Shao et al. (2016) Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas. Am J Surg Pathol 40:433-42
Huang, Shih-Chiang; Ghossein, Ronald A; Bishop, Justin A et al. (2016) Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation. Am J Surg Pathol 40:51-9
Dickson, Mark A; Schwartz, Gary K; Keohan, Mary Louise et al. (2016) Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. JAMA Oncol 2:937-40

Showing the most recent 10 out of 336 publications